Centiva Capital, LP

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1692507 New York, NY

Back to UTHR Full portfolio

Position in UTHR

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

-$846,068 QoQ

Shares Held

-100.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2021

7 quarters on record

Common Shares in UTHR Over Time

Shares Held

Position Value (USD)

Derivatives in UTHR

reported options exposure · as of Mar 31, 2026

CallValue

$18,678,870

CallShares

31,500

PutValue

$11,859,600

PutShares

20,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Centiva Capital, LP holds $2,208,307 across 5 Drug Manufacturers - Specialty & Generic names.

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	69,852	$1,109,249
2	HIMS	Hims & Hers Health, Inc.	21,949	$760,971
3	ZTS	Zoetis Inc.	3,326	$239,006
4	ALVO	Alvotech	21,724	$80,161
5	ADCT	ADC Therapeutics SA	17,683	$18,920

All Filings in UTHR

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$11,859,600	20,000	—	Put	Sole	2026-05-14
2026-03-31	$18,678,870	31,500	—	Call	Sole	2026-05-14
2024-06-30	$846,068	2,656	+148.5%	Shares	Sole	2024-08-14
2023-12-31	$235,061	1,069	-14.5%	Shares	Other	2024-02-14
2023-09-30	$282,337	1,250	-28.5%	Shares	Sole	2023-11-14
2021-09-30	$322,645	1,748	-38.1%	Shares	Sole	2021-11-17
2021-06-30	$506,474	2,823	+133.9%	Shares	Sole	2021-08-16
2021-03-31	$201,894	1,207	—	Shares	Sole	2021-05-17
No filing history on record for this holder in this stock.